Why drug combinations are the future of treatment in CLL
Development of blood clots in multiple myeloma patients treated with immunomodulatory drugs.
The potential of palbociclib for the treatment of FLT3-ITD+ AML
The CLL patient: devising a management plan
How to manage infections in CLL patients on idelalisib